Canon sees first profit gain in 3 years after medical unit acquisition


A man walks past a Canon logo in Tokyo, Japan, October 27, 2015. REUTERS/Toru Hanai/Files

TOKYO: Japanese camera and printer maker Canon Inc forecast full-year operating profit to climb 11.4%, its first rise in three years, bolstered by earnings from a medical equipment unit it bought from Toshiba Corp last year.

The US$5.8 billion acquisition of the unit, which makes X-ray scanners and eye examination machines, is part of Canon's strategy to diversify as demand for its cameras, printers and copier machines wanes amid the spread of smartphones and paperless media.

The company forecast operating profit to rise to 255 billion yen (US$2.3 billion) this year from 228.9 billion in the previous 12 months - in line with an average analyst estimate of 254 billion yen from 19 analysts surveyed by Thomson Reuters I/B/E/S.

Fourth-quarter operating profit fell 25.1% to 80.2 billion yen from a year earlier, hurt after the yen strengthened following Britain's vote in June to leave the European Union.

That was below a consensus estimate of 88.5 billion yen from four analysts. - Reuters

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Mi Tech to reap China demand for test handlers
Ringgit retreats to open easier ahead of US inflation readings
Farm Price's share price surges 100% on trading debut
FBM KLCI moves sideways ahead of key economic data
Trading ideas: TM, MISC, Capital A, PTT, Aurelius Tech, AME Elite, Score Builders, YNHP, Frontken and Mulpha
S&P 500 barely changes as investors hold tight ahead of inflation data
HDBank targets high growth with ESG strategy
France gets investments from Amazon, Pfizer and Morgan Stanley
Investors in best hedge fund bet of 2023 review climate assumptions
Profit-taking pressures rise amid resistance

Others Also Read